Patent Assignment
Reel/Frame 039462/0247
Assignment of Assignor's Interest
Recorded: 2016-07-26
Pages: 7
Assignor
NOVARTIS PHARMA AG
Executed: 2015-03-02
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, BASEL, SWITZERLAND
Covered Properties
(43)
Cancer Treatment Method
Application:
12/166,686 →
Publication:
US 2009/0022814
Methods for Treating Degenerative Diseases/Injuries
Application:
12/496,867 →
Publication:
US 2010/0004302
Cancer Treatment Method
Application:
12/527,220 →
Publication:
US 2010/0075928
Cancer Treatment Method
Application:
12/948,159 →
Publication:
US 2011/0129550
Method of Treating Thrombocytopenia
Application:
13/124,182 →
Publication:
US 2012/0149749
CRYSTALLINE N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
Application:
13/146,493 →
Publication:
US 2011/0288142
3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE)
Application:
13/334,770 →
Publication:
US 2012/0189576
Combination
Application:
13/497,576 →
Publication:
US 2012/0322817
Combination
Application:
13/497,580 →
Publication:
US 2012/0283278
Combination
Application:
13/509,955 →
Publication:
US 2012/0283279
Combination
Application:
13/699,103 →
Publication:
US 2013/0237554
Methods for Treating Degenerative Diseases/Injuries
Application:
13/749,047 →
Publication:
US 2013/0137736
Cancer Treatment Method
Application:
13/906,591 →
Publication:
US 2014/0038982
CRYSTALLINE N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
Application:
14/083,617 →
Publication:
US 2014/0073679
Thrombopoietin mimetics
Application:
60/207,084 →
Thrombopoietin mimetics
Application:
60/228,929 →
3'-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid bis-(monoethanolamine)
Application:
60/382,871 →
Novel compound, corresponding compositions, preparation and/or treatment methods
Application:
60/519,160 →
Novel compound, corresponding compositions, preparation and/or treatment methods
Application:
60/524,574 →
Inhibitors of Akt Activity
Application:
60/888,586 →
Cancer Treatment Method
Application:
60/890,236 →
Antibody Formulations
Application:
60/948,220 →
Benzene Sulfonamide Thiazole and Oxazole Compounds
Application:
61/050,744 →
CRYSTALLINE N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
Application:
61/148,490 →
Method of Treating Thrombocytopenia
Application:
61/176,303 →
Methods of Administration of Thrombopoietin Agonist Compounds
Application:
61/182,148 →
Combination
Application:
61/245,019 →
Combination
Application:
61/245,027 →
Combination
Application:
61/249,808 →
Combination
Application:
61/250,635 →
Combination
Application:
61/252,213 →
Combination
Application:
61/261,813 →
Combination
Application:
61/346,992 →
Combination
Application:
61/348,385 →
Combination
Application:
61/377,196 →
Combination of BRAF and VEGF Inhibitors
Application:
61/382,511 →
Methods of Treating Cancer
Application:
61/422,715 →
Combination
Application:
61/424,961 →
Combination
Application:
61/431,508 →
Method of Adjuvant Cancer Treatment
Application:
61/696,375 →
Combination
Application:
61/716,790 →
Combination
Application:
61/718,430 →
Combination
Application:
61/730,192 →
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Aug 23, 2010
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 024869/0041 →
Assignment of Assignor's Interest
Sep 15, 2010
From: KUMAR, RAKESH
To: GLAXOSMITHKLINE LLC
Reel/Frame 024987/0967 →
Assignment of Assignor's Interest
Sep 15, 2010
From: GILMER, TONA M.; KUMAR, RAKESH
To: GLAXOSMITHKLINE LLC
Reel/Frame 024987/0908 →
Assignment of Assignor's Interest
Jun 15, 2012
From: ERICKSON-MILLER, CONNIE LYNN
To: GLAXOSMITHKLINE LLC
Reel/Frame 028384/0232 →
Change of Name
Jan 24, 2013
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 029683/0743 →
Assignment of Assignor's Interest
Jan 24, 2013
From: ERICKSON-MILLER, CONNIE L; JENKINS, JULIAN
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 029683/0705 →
Assignment of Assignor's Interest
Jan 25, 2013
From: ERICKSON-MILLER, CONNIE L; JENKINS, JULIAN
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 029692/0224 →
Change of Name
Jan 25, 2013
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 029698/0221 →
Assignment of Assignor's Interest
May 31, 2013
From: ERICKSON-MILLER, CONNIE L.
To: GLAXOSMITHKLINE LLC
Reel/Frame 030523/0808 →
Assignment of Assignor's Interest
Nov 21, 2013
From: CHEN, PINGYUN Y.; GAULDING, JEFFREY
To: GLAXOSMITHKLINE LLC
Reel/Frame 031648/0713 →
Change of Name
May 15, 2014
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 032908/0438 →
Assignment of Assignor's Interest
May 15, 2014
From: MOORE, STEPHEN
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 032903/0857 →
Assignment of Assignor's Interest
Jul 25, 2016
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED
To: NOVARTIS PHARMA AG
Reel/Frame 039240/0247 →
Assignment of Assignor's Interest
Jul 26, 2016
From: GLAXO GROUP LIMITED
To: NOVARTIS PHARMA AG
Reel/Frame 039249/0881 →
Assignment of Assignor's Interest
Jul 26, 2016
From: GLAXOSMITHKLINE
To: GLAXO GROUP LIMITED
Reel/Frame 039249/0813 →
Assignment of Assignor's Interest
Jul 26, 2016
From: GLAXOSMITHKLINE LLC
To: NOVARTIS PHARMA AG
Reel/Frame 039249/0781 →
Assignment of Assignor's Interest
Jul 26, 2016
From: GLAXOSMITHKLINE LLC
To: GLAXO GROUP LIMITED
Reel/Frame 039249/0771 →
Assignment of Assignor's Interest
Jul 26, 2016
From: GLAXOSMITHKLINE
To: NOVARTIS PHARMA AG
Reel/Frame 039249/0809 →
Assignment of Assignor's Interest
Dec 5, 2023
From: NOVARTIS AG
To: NOVARTIS PHARMACEUTICALS CORPORATION
Reel/Frame 065762/0911 →